Annual EBIT
-$12.52 M
-$10.46 M-505.76%
December 31, 2023
Summary
- As of February 7, 2025, MEDS annual earnings before interest & taxes is -$12.52 million, with the most recent change of -$10.46 million (-505.76%) on December 31, 2023.
- During the last 3 years, MEDS annual EBIT has fallen by -$10.02 million (-399.55%).
Performance
MEDS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$2.97 M
-$1.35 M-83.12%
September 30, 2024
Summary
- As of February 7, 2025, MEDS quarterly earnings before interest & taxes is -$2.97 million, with the most recent change of -$1.35 million (-83.12%) on September 30, 2024.
- Over the past year, MEDS quarterly EBIT has increased by +$3.57 million (+54.63%).
Performance
MEDS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$22.14 M
-$3.05 M-15.96%
September 30, 2024
Summary
- As of February 7, 2025, MEDS TTM earnings before interest & taxes is -$22.14 million, with the most recent change of -$3.05 million (-15.96%) on September 30, 2024.
- Over the past year, MEDS TTM EBIT has dropped by -$2.62 million (-13.41%).
Performance
MEDS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MEDS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -505.8% | +54.6% | -13.4% |
| 3 y3 years | -399.6% | -128.8% | -224.8% |
| 5 y5 years | -10000.0% | -7334.6% | -9478.9% |
MEDS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +505.8% | at low | -3798.5% | +271.3% | +784.7% | at low |
| 5 y | 5-year | +5316.2% | at low | -1676.1% | +271.3% | >+9999.0% | at low |
| alltime | all time | -2907.7% | +127.6% | -825.9% | +860.1% | -5063.4% | +28.8% |
TRxADE HEALTH EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.97 M(+83.1%) | -$22.14 M(+16.0%) |
| Jun 2024 | - | -$1.62 M(-75.2%) | -$19.09 M(-2.2%) |
| Mar 2024 | - | -$6.54 M(-40.6%) | -$19.52 M(+38.9%) |
| Dec 2023 | -$12.52 M(+505.8%) | -$11.01 M(<-9900.0%) | -$14.05 M(+330.3%) |
| Sep 2023 | - | $80.20 K(-103.9%) | -$3.27 M(-8.2%) |
| Jun 2023 | - | -$2.05 M(+90.7%) | -$3.56 M(+36.2%) |
| Mar 2023 | - | -$1.07 M(+379.3%) | -$2.61 M(+4.4%) |
| Dec 2022 | -$2.07 M(-60.9%) | -$224.10 K(+6.5%) | -$2.50 M(-18.2%) |
| Sep 2022 | - | -$210.40 K(-80.9%) | -$3.06 M(-26.2%) |
| Jun 2022 | - | -$1.10 M(+14.4%) | -$4.15 M(-26.1%) |
| Mar 2022 | - | -$964.50 K(+23.3%) | -$5.61 M(+6.1%) |
| Dec 2021 | -$5.29 M(+111.1%) | -$782.30 K(-39.6%) | -$5.29 M(-22.3%) |
| Sep 2021 | - | -$1.30 M(-49.6%) | -$6.82 M(+26.8%) |
| Jun 2021 | - | -$2.57 M(+298.8%) | -$5.37 M(+60.9%) |
| Mar 2021 | - | -$644.30 K(-72.1%) | -$3.34 M(+33.2%) |
| Dec 2020 | -$2.51 M(+984.2%) | -$2.31 M(-1681.2%) | -$2.51 M(+263.2%) |
| Sep 2020 | - | $145.80 K(-127.2%) | -$690.10 K(-13.2%) |
| Jun 2020 | - | -$535.30 K(-384.4%) | -$794.90 K(+328.1%) |
| Mar 2020 | - | $188.20 K(-138.5%) | -$185.70 K(-19.6%) |
| Dec 2019 | -$231.20 K(-447.1%) | -$488.80 K(-1292.2%) | -$231.10 K(-365.0%) |
| Sep 2019 | - | $41.00 K(-44.5%) | $87.20 K(-43.0%) |
| Jun 2019 | - | $73.90 K(-48.2%) | $153.10 K(+38.4%) |
| Mar 2019 | - | $142.80 K(-183.8%) | $110.60 K(+66.3%) |
| Dec 2018 | $66.60 K(-85.1%) | -$170.50 K(-259.5%) | $66.50 K(-83.3%) |
| Sep 2018 | - | $106.90 K(+240.4%) | $397.20 K(-0.1%) |
| Jun 2018 | - | $31.40 K(-68.2%) | $397.40 K(-1.5%) |
| Mar 2018 | - | $98.70 K(-38.4%) | $403.30 K(-9.6%) |
| Dec 2017 | $446.00 K | $160.20 K(+49.6%) | $446.00 K(+75.0%) |
| Sep 2017 | - | $107.10 K(+187.1%) | $254.80 K(-361.3%) |
| Jun 2017 | - | $37.30 K(-73.6%) | -$97.50 K(-87.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $141.40 K(-556.1%) | -$750.00 K(-26.6%) |
| Dec 2016 | -$1.02 M(+645.1%) | -$31.00 K(-87.4%) | -$1.02 M(+75.5%) |
| Sep 2016 | - | -$245.20 K(-60.1%) | -$582.10 K(+40.8%) |
| Jun 2016 | - | -$615.20 K(+372.1%) | -$413.50 K(-335.9%) |
| Mar 2016 | - | -$130.30 K(-131.9%) | $175.30 K(-227.9%) |
| Dec 2015 | -$137.10 K(-93.2%) | $408.60 K(-633.4%) | -$137.10 K(-86.1%) |
| Sep 2015 | - | -$76.60 K(+190.2%) | -$982.80 K(-21.8%) |
| Jun 2015 | - | -$26.40 K(-94.0%) | -$1.26 M(-17.9%) |
| Mar 2015 | - | -$442.70 K(+1.3%) | -$1.53 M(-23.8%) |
| Dec 2014 | -$2.01 M(-3.7%) | -$437.10 K(+25.0%) | -$2.01 M(-33.2%) |
| Sep 2014 | - | -$349.80 K(+16.6%) | -$3.00 M(+2.3%) |
| Jun 2014 | - | -$300.00 K(-67.4%) | -$2.94 M(+4.1%) |
| Mar 2014 | - | -$920.90 K(-35.7%) | -$2.82 M(+48.5%) |
| Dec 2013 | -$2.08 M(-92.7%) | -$1.43 M(+406.7%) | -$1.90 M(+307.0%) |
| Sep 2013 | - | -$282.80 K(+53.8%) | -$466.70 K(+153.8%) |
| Jun 2013 | - | -$183.90 K(+3986.7%) | -$183.90 K(-99.4%) |
| Sep 2009 | - | -$4500.00(+73.1%) | -$28.51 M(+0.0%) |
| Jun 2009 | - | -$2600.00(-86.2%) | -$28.50 M(-0.0%) |
| Mar 2009 | - | -$18.90 K(-99.9%) | -$28.51 M(+0.0%) |
| Dec 2008 | -$28.50 M(>+9900.0%) | -$28.48 M(>+9900.0%) | -$28.50 M(>+9900.0%) |
| Sep 2008 | - | -$4000.00(-38.5%) | -$26.20 K(-11.2%) |
| Jun 2008 | - | -$6500.00(-8.5%) | -$29.50 K(-15.0%) |
| Mar 2008 | - | -$7100.00(-17.4%) | -$34.70 K(+23.0%) |
| Dec 2007 | -$28.20 K(+224.1%) | -$8600.00(+17.8%) | -$28.20 K(+23.7%) |
| Sep 2007 | - | -$7300.00(-37.6%) | -$22.80 K(+33.3%) |
| Jun 2007 | - | -$11.70 K(+1850.0%) | -$17.10 K(+83.9%) |
| Mar 2007 | - | -$600.00(-81.3%) | -$9300.00(+6.9%) |
| Dec 2006 | -$8700.00 | -$3200.00(+100.0%) | -$8700.00(+58.2%) |
| Sep 2006 | - | -$1600.00(-59.0%) | -$5500.00(+41.0%) |
| Jun 2006 | - | -$3900.00 | -$3900.00 |
FAQ
- What is TRxADE HEALTH annual earnings before interest & taxes?
- What is the all time high annual EBIT for TRxADE HEALTH?
- What is TRxADE HEALTH annual EBIT year-on-year change?
- What is TRxADE HEALTH quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TRxADE HEALTH?
- What is TRxADE HEALTH quarterly EBIT year-on-year change?
- What is TRxADE HEALTH TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TRxADE HEALTH?
- What is TRxADE HEALTH TTM EBIT year-on-year change?
What is TRxADE HEALTH annual earnings before interest & taxes?
The current annual EBIT of MEDS is -$12.52 M
What is the all time high annual EBIT for TRxADE HEALTH?
TRxADE HEALTH all-time high annual earnings before interest & taxes is $446.00 K
What is TRxADE HEALTH annual EBIT year-on-year change?
Over the past year, MEDS annual earnings before interest & taxes has changed by -$10.46 M (-505.76%)
What is TRxADE HEALTH quarterly earnings before interest & taxes?
The current quarterly EBIT of MEDS is -$2.97 M
What is the all time high quarterly EBIT for TRxADE HEALTH?
TRxADE HEALTH all-time high quarterly earnings before interest & taxes is $408.60 K
What is TRxADE HEALTH quarterly EBIT year-on-year change?
Over the past year, MEDS quarterly earnings before interest & taxes has changed by +$3.57 M (+54.63%)
What is TRxADE HEALTH TTM earnings before interest & taxes?
The current TTM EBIT of MEDS is -$22.14 M
What is the all time high TTM EBIT for TRxADE HEALTH?
TRxADE HEALTH all-time high TTM earnings before interest & taxes is $446.00 K
What is TRxADE HEALTH TTM EBIT year-on-year change?
Over the past year, MEDS TTM earnings before interest & taxes has changed by -$2.62 M (-13.41%)